期刊文献+

喉癌组织核因子-κB诱导激酶表达临床意义研究 被引量:3

Expression and clinical significance of NF-κB inducing kinase in laryngeal cancer
原文传递
导出
摘要 目的核因子-κB诱导激酶(nuclear factor-κB inducing kinase,NIK)在多种肿瘤细胞中高表达,但其在喉癌中的表达情况目前尚不清楚。为此,本研究探讨NIK蛋白在喉癌组织中的表达及其临床意义。方法收集河北医科大学第三医院2000-01-01-2010-09-30接受手术治疗的63例喉癌患者的术中切除标本,所有患者均经术后病理确诊。采用免疫组织化学方法检测NIK蛋白在喉癌及癌旁正常组织中的表达水平,探讨NIK表达水平与患者的预后和临床病理特征的相关性。结果 NIK在喉癌组织中的阳性表达率为60.3%(38/63),显著高于癌旁正常组织的9.5%(6/63),χ2=35.76,P<0.001。NIK的表达与患者的性别(χ2=0.02,P=0.881)、年龄(χ2=0.027,P=0.867)、分化程度(χ2=0.14,P=0.932)和肿瘤部位(χ2=2.36,P=0.127)无关,而与患者的临床分期(χ2=13.7,P=0.003)和有无淋巴结转移(χ2=20.2,P<0.001)显著相关。NIK阳性表达的喉癌患者5年生存率为28.6%,显著低于阴性表达患者的80.9%,χ2=4.07,P=0.043。多因素Cox比例风险回归模型分析进一步显示,NIK蛋白表达水平为喉癌患者预后的独立影响因素,P=0.022。结论 NIK在喉癌组织中的表达明显升高,可能是影响患者预后的重要因素。 OBJECTIVE Nuclear factor-κB inducing kinase (NIK) is often highly expressed in tumor cells,but the clinical significance in laryngeal cancer has been unclear. The current study was to evaluate the expression of NIK in la- ryngeal cancer from protein level and the impact of NIK expression on clinicopathologic data. METHODS Specimens from 63 patients with laryngeal cancer managed in the Third Affiliated Hospital of Hebei Medical University between January 01,2000 and September 30,2010 were included in this study. Immunohistochemical staining was used to detect the expression of NIK in 63 cases of laryngeal cancer and 63 cases of normal esophageal mucosal tissues. All the specimens were confirmed by pathology for laryngeal cancer or esophageal normal larynx tissues. RESULTS The positive expres- sion rate of NIK in laryngeal cancer and normal larynx tissues were 60.3% (38/63) and 9.5% (6/63), respectively. The positive expression rate of NIK in laryngeal cancer was significantly higher than those in normal larynx tissues (;(2 = 35.76,P〈0. 001). The positive expression rate of NIK in laryngeal dancer was not related with the sex(X^2=0.02,P= 0. 881, age(X^2=0. 027, P= 0. 867), tumor differentiation (X^2 = 0. 14, P= 0. 932) and tumor location(X^2 : 2.36, P = 0.127),but with clinical stage (X^2=13.7,P=0.003)and lymph node metastasis(x2=20. 2,P〈0. 001). Patients with positive NIK expression had significantly lower five-year survival rate than those with tumors having positive NIK expres- sion(28.6%vs 80.9%, X^2 = 4.07, P= 0. 043). Multivariate Cox regression analysis revealed that NIK overexpression was an independent prognostic factor for patients with laryngeal cancer (P=0. 022). CONCLUSION The expression of NIK is increased in laryngeal cancer, which has certain reference value for estimating prognosis of laryngeal cancer patients.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2016年第13期856-859,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 河北省自然科学基金(H2015206409)
关键词 喉肿瘤 核因子-κB诱导激酶 免疫组织化学染色 预后 laryngeal neoplasms NIK immunohistochemical staining prognosis
  • 相关文献

参考文献16

  • 1胡尚英,陈万青,赵方辉,张思维,郑荣寿,乔友林.中国2003--2007年口腔和咽喉癌发病与死亡分析[J].中华流行病学杂志,2013,34(2):164-167. 被引量:8
  • 2马泓智,冯凌,李平栋,侯丽珍,周维国,陈学军,陈晓红,黄志刚,房居高.中晚期喉癌颈淋巴结转移规律相关因素分析[J].中华肿瘤防治杂志,2015,22(7):542-547. 被引量:18
  • 3郭修栋,兰胜民,曹建忠,王宏卫,罗宁,鲁萍,张红云,李蓉.喉鳞癌患者预后影响因素的回顾性分析[J].中华肿瘤防治杂志,2011,18(8):606-609. 被引量:9
  • 4Focht KL, Martin-Harris B, Bonilha HS. Stroboscopic parame-ters reported as voice outcome measures in patients treated forlaryngeal cancer: A systematic review[J], J Med Speech LangPathol,2013,21(3) :715-721.
  • 5Yoshida K,Sasaki R?Nishimura H,et al. Nuclear factor-kappaBexpression as a novel marker of radioresistance in early-stage la-ryngeal cancer[J]. Head Neck,2010,32(5) :646-655.
  • 6Rades D, Huttenlocher S, Seibold ND’et al. Nuclear expressionof p65 (RelA) in patients receiving post-operative radiotherapyfor locally advanced squamous cell carcinoma of the head andneck[J], BMC Cancer,2015,15 : 102 :172-179.
  • 7Rapino F* Abhari BA,Jung M, et al. NIK is required for NF-kappaB-mediated induction of BAG3 upon inhibition of constitu-tive protein degradation pathways[J/CD]. Cell Death Dis,2015,6(2):el692.
  • 8Sato-Tadano A, Suzuki T, Amari M, et al. Hexokinase H in breastcarcinoma : a potent prognostic factor associated with hypoxia-induc-ible factor-lalpha and Ki-67 [J], Cancer Sci* 2013,104 (10) : 1380-1388.
  • 9刘宏侠,孙玉满,杨俊泉,曹渤海,吴蒙,王宝良,张玲,韩凤艳.喉癌与手术切缘组织PCNA和Cdc2表达与局部复发相关性研究[J].中华肿瘤防治杂志,2014,21(21):1701-1705. 被引量:3
  • 10Tong L, Yuan Y, Wu S. Therapeutic microRNAs targeting theNF-kappa B signaling circuits of cancers [J]. Adv Drug DelivRev,2015,81(3):M5.

二级参考文献55

  • 1杨功焕,马杰民,刘娜,周灵妮.中国人群2002年吸烟和被动吸烟的现状调查[J].中华流行病学杂志,2005,26(2):77-83. 被引量:1054
  • 2马冠生,朱丹红,胡小琪,栾德春,孔灵芝,杨晓光.中国居民饮酒行为现况[J].营养学报,2005,27(5):362-365. 被引量:192
  • 3于文斌,曾宗渊.采用手术加辅助放疗的声门上型喉癌患者预后多因素分析[J].中华肿瘤防治杂志,2006,13(2):127-129. 被引量:4
  • 4Forastiere A A, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapyfor organ preservation in advanced laryngealcancer[J]. N Engl J Med, 2003,349(22) :2091-2098.
  • 5Cortesina G,De Stefani A,Cavalot A,et al. Current role of radiotherapy in tb.e treatment of locally advanced laryngeal careinomas[J]. J Surg Oncol,2000,74(1) :79-82.
  • 6Jacques B, Christian D,Mahmut O,et al. Postoperative Irradia tion with or without concomitant chemotherapy for locally ad vanced head and neck cancer[J]. N Engl J Med, 2004,350(19) 1945-1952.
  • 7Francesco C. Docetaxel in the management of head and neck cancer [J]. Anti-Cancer Drugs, 2009,20(8) :639-645.
  • 8Cooper J S, Pajak T F, Forastiere A A, et al. Postoperative concurrent radiotherapy and chemotherapyfor high-risk squamous-cell carcinoma of the head and neck[J]. N Engl J Med, 2004,350(19) : 1937-1944.
  • 9Cortesina G, De Stefani A, Cavalot A, et al. Current role of radiotherapy in the treatment of locally advanced laryngeal carcinomas [J]. Surg Oncol,2000,74(1):79-82.
  • 10Rubinstein M, William B. Armstrong,et al. Transoral laser mi- crosurgery for laryngeal cancer: A primer and review of laser [J].Lasers Med Sci, 2011, 26(1):113-124.

共引文献34

同被引文献24

引证文献3

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部